Epigral zoomed 11.72% to Rs 1,642.65 after the company’s consolidated net profit stood at Rs 86 crore in Q1 FY25, steeply higher than Rs 32 crore posted in corresponding quarer last year.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
